Form 4 for GH Guardant Health, Inc.
Accepted 2025-04-02 00:00:00 ET · period of report 2025-03-31 · accession 0001576280-25-000106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-02 | 2025-03-31+ | GH | Talasaz AmirAli | Co-CEO, Dir | F - Tax | $42.49 | -14.6K | 2.31M | -0.6% | -$620.5K |
| DM | 2025-04-02 | 2025-03-31+ | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | +28.8K | 2.32M | +1% | $0 |
| DM | 2025-04-02 | 2025-03-31+ | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | -28.8K | 168.0K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-31 | F | D | 2,440 | $42.60 | 2,297,621 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 2 | Common | Common Stock | 2025-04-01 | F | D | 12,163 | $42.47 | 2,309,456 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 3 | Common | Common Stock | 2025-03-31 | M | A | 4,814 | $0.00 | 2,300,061 | D | — | — | |
| 4 | Common | Common Stock | 2025-04-01 | M | A | 23,998 | $0.00 | 2,321,619 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2025-03-31 | M | D | 4,814 | $0.00 | 14,444 | D | $0.00 · — to — | 4,814 Common Stock | (F2) This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. (F3) Not applicable for Restricted Stock Units. |
| 6 | Derivative | Restricted Stock Units | 2025-04-01 | M | D | 23,998 | $0.00 | 167,980 | D | $0.00 · — to — | 23,998 Common Stock | (F4) This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. (F3) Not applicable for Restricted Stock Units. |